Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 Monocytes
Open Access
- 1 July 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (7), 2139-2143
- https://doi.org/10.2337/diacare.26.7.2139
Abstract
OBJECTIVE—Diabetic patients have elevated blood levels of interleukin-6 (IL-6), which is known to increase inflammation and the development of vascular disease and atherosclerosis. This study examined the hypothesis that ketosis increases the circulating levels of IL-6 in type 1 diabetic patients as well as the secretion of IL-6 in vitro in a cell culture model using U937 monocytes. RESEARCH DESIGN AND METHODS—Fasting blood was obtained from type 1 diabetic patients and healthy siblings. To examine the effect of ketosis, U937 monocytes were cultured with ketone bodies (acetoacetate [AA], β-hydroxybutyrate [BHB]) in the presence or absence of high glucose levels in the medium at 37°C for 24 h. IL-6 was determined by the sandwich enzyme-linked immunosorbent assay method, and intracellular reactive oxygen species (ROS) generation was detected using dihydroethidium dye. RESULTS—The blood level of IL-6 was higher in hyperketonemic (HK) diabetic patients than in normoketonemic (NK) diabetic patients (P < 0.05) and normal control subjects (P < 0.05). There was a significant correlation between ketosis and IL-6 levels (r = 0.36, P < 0.04, n = 34) in the blood of diabetic patients. Cell culture studies found that exogenous addition of the ketone body AA, but not BHB, increases IL-6 secretion and ROS generation in U937 cells. N-acetylcysteine (NAC) prevented the IL-6 secretion in acetoacetate-treated U937 monocytes. CONCLUSIONS—This study demonstrates that hyperketonemia increases IL-6 levels in the blood of type 1 diabetic patients and that NAC can inhibit IL-6 secretion by U937 monocytic cells cultured in a ketotic medium.This publication has 31 references indexed in Scilit:
- Chromium Chloride Inhibits Oxidative Stress and TNF-α Secretion Caused by Exposure to High Glucose in Cultured U937 MonocytesBiochemical and Biophysical Research Communications, 2001
- Thyroid-stimulating Hormone and Cyclic AMP Activate p38 Mitogen-activated Protein Kinase CascadeOnline Journal of Public Health Informatics, 2000
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000
- Effect of Hyperketonemia on Blood Monocytes in Type-I Diabetic Patients and Apoptosis in Cultured U937 MonocytesAntioxidants and Redox Signaling, 1999
- Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide TreatmentDiabetes Care, 1998
- Free Radicals Generated during the Glycation Reaction of Amino Acids by MethylglyoxalPublished by Elsevier BV ,1995
- The Effect of Glucose and Advanced Glycosylation End Products on IL‐6 Production by Human MonocytesAnnals of the New York Academy of Sciences, 1994
- In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitusJournal of Clinical Endocrinology & Metabolism, 1993
- Glucose induces lipid peroxidation and inactivation of membrane‐associated ion‐transport enzymes in human erythrocytes in vivo and in vitroJournal of Cellular Physiology, 1991
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990